To investigate the underlying molecular mechanisms by which DEF modulates pancreatic cancer progression, we performed RNA sequencing on PANC1 cells to identify transcriptomic changes following DEF KD (Figure 4c). The gene discussed is UTP25; the disease is pancreatic neoplasm.